We are live on ! Find out more
DCM

DAFNA Capital Management Portfolio holdings

AUM $440M
1-Year Est. Return 109.12%
This Fund
S&P 500
This Quarter Est. Return
+12.76%
1 Year Est. Return
+109.12%
3 Year Est. Return
+239.59%
5 Year Est. Return
+227.89%
10 Year Est. Return
+3,611.91%
AUM
$478M
AUM Growth
+$56.7M
Cap. Flow
+$17.4M
Cap. Flow %
3.64%
Top 10 Hldgs %
53.49%
Holding
96
New
7
Increased
25
Reduced
16
Closed
12

Top Buys

1
TBPH icon
Theravance Biopharma
TBPH
+$13M
2
FSTX
F-star Therapeutics, Inc. Common Stock
FSTX
+$6.09M
3
OTIC
Otonomy, Inc.
OTIC
+$4.6M
4
TBIO
Translate Bio, Inc. Common Stock
TBIO
+$2.98M
5
ARNA
Arena Pharmaceuticals Inc
ARNA
+$2.8M

Top Sells

1
PLX icon
Protalix BioTherapeutics
PLX
+$5.37M
2
ATRC icon
AtriCure
ATRC
+$2.69M
3
ALEC icon
Alector
ALEC
+$2.57M
4
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
+$2.36M
5
AGTC
Applied Genetic Technologies Corporation
AGTC
+$2.18M

Sector Composition

1 Healthcare 90.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STXS icon
1
Stereotaxis
STXS
$161M
$132M 27.58%
13,680,554
– –
FATE icon
2
Fate Therapeutics
FATE
$349M
$27.3M 5.71%
314,360
– –
DRNA
3
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$19.1M 3.99%
510,756
-77,000
-13% -$2.36M
BPMC
4
DELISTED
Blueprint Medicines
BPMC
$18.3M 3.82%
207,911
– –
TBPH icon
5
Theravance Biopharma
TBPH
$877M
$10.6M 2.22%
732,345
+691,180
+1,679% +$13M
MORF
6
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$10.4M 2.18%
181,467
– –
TBIO
7
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$10.4M 2.17%
376,993
+151,600
+67% +$2.98M
SAGE
8
DELISTED
Sage Therapeutics
SAGE
$9.68M 2.02%
170,306
-11,000
-6% -$778K
BHVN
9
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$9.13M 1.91%
94,100
+500
+0.5% +$40.6K
DXCM icon
10
DexCom
DXCM
$28.1B
$9.03M 1.89%
84,552
– –
AFMD
11
DELISTED
Affimed
AFMD
$8.2M 1.72%
96,486
-2,500
-3% -$228K
ARNA
12
DELISTED
Arena Pharmaceuticals Inc
ARNA
$8.16M 1.71%
119,615
+42,900
+56% +$2.8M
NRIX icon
13
Nurix Therapeutics
NRIX
$2.48B
$8.13M 1.7%
306,320
– –
XENE icon
14
Xenon Pharmaceuticals
XENE
$6.55B
$7.57M 1.58%
406,535
– –
ATRC icon
15
AtriCure
ATRC
$1.75B
$7.26M 1.52%
91,529
-37,000
-29% -$2.69M
NBIX icon
16
Neurocrine Biosciences
NBIX
$17.3B
$7.17M 1.5%
73,655
– –
IDYA icon
17
IDEAYA Biosciences
IDYA
$3.54B
$6.96M 1.46%
331,661
– –
PRQR icon
18
ProQR Therapeutics
PRQR
$250M
$6.96M 1.45%
1,031,880
-68,120
-6% -$439K
IBB icon
19
iShares Biotechnology ETF
IBB
$9.24B
$6.69M 1.4%
40,900
+500
+1% +$77K
RVMD icon
20
Revolution Medicines
RVMD
$39.2B
$6.66M 1.39%
209,731
+58,500
+39% +$2.04M
CSII
21
DELISTED
Cardiovascular Systems, Inc.
CSII
$6.38M 1.34%
149,700
– –
FSTX
22
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$6.14M 1.28%
+714,285
New +$6.09M
KRTX
23
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$6.04M 1.26%
53,000
+5,000
+10% +$584K
LKFT
24
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.93B
$5.35M 1.12%
77,675
+2,500
+3% +$191K
OTIC
25
DELISTED
Otonomy, Inc.
OTIC
$5.31M 1.11%
2,379,392
+1,989,800
+511% +$4.6M
1
2 3 4

Similar funds

FGWP
Founders Grove Wealth Partners Richmond, Virginia $440M AUM 16.56% 1-Year Est. Return
STCG
Speece Thorson Capital Group Minnetonka, Minnesota $439M AUM 10.15% 1-Year Est. Return
SCP
SailingStone Capital Partners Houston, Texas $440M AUM 127.21% 1-Year Est. Return
CAAM
Cape Ann Asset Management London, United Kingdom $440M AUM 96.23% 1-Year Est. Return
AWM
Austin Wealth Management Austin, Texas $440M AUM 17.66% 1-Year Est. Return
HCM
Harvey Capital Management Palm Beach, Florida $439M AUM 37.68% 1-Year Est. Return
CPW
Cove Private Wealth Oyster Bay Cove, New York $440M AUM 27.56% 1-Year Est. Return
DWML
Decker Wealth Management LLC Nashville, Tennessee $440M AUM